Brief: Oramed Signs Definitive Deal With Medicox To Commercialize Oral Insulin In South Korea
14/11/2022 12:59
Nov 14 (Reuters) - Medicox Co Ltd 054180.KQ :
* ORAMED SIGNS DEFINITIVE DEAL WITH MEDICOX TO COMMERCIALIZE
ORAL
INSULIN IN SOUTH KOREA
* ORAMED PHARMACEUTICALS INC - MEDICOX WILL PURCHASE
ORMD-0801 AT
AN AGREED UPON TRANSFER PRICE AND WILL ADDITIONALLY PAY ORAMED
UP TO $18 MILLION
* ORAMED PHARMACEUTICALS INC - MEDICOX WILL ADDITIONALLY BE
RESPONSIBLE FOR GAINING REGULATORY APPROVAL IN REPUBLIC OF KOREA
* ORAMED PHARMACEUTICALS INC - MEDICOX TO DISTRIBUTE
ORAMED'S ORAL
INSULIN IN SOUTH KOREA, IF APPROVED
Source text for Eikon: ID:nPnbC7jt2a
Further company coverage: 054180.KQ
Recent news on Medicox
See all newsBrief: Medicox To Conduct Capital Increase Of 1 Billion Won For Operational Funds
Brief: Oramed Signs Definitive Deal With Medicox To Commercialize Oral Insulin In South Korea
Brief: ChoongAng Ocean raises 1 bln won in private placement
Brief: ChoongAng Ocean issues 13th tranche convertible bonds worth 6.6 bln won
Brief: ChoongAng Ocean to raise 1 bln won via private placement